Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
616
-
Total 13F shares, excl. options
-
274M
-
Shares change
-
-17M
-
Total reported value, excl. options
-
$7.09B
-
Value change
-
-$452M
-
Put/Call ratio
-
1.09
-
Number of buys
-
254
-
Number of sells
-
-313
-
Price
-
$25.83
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q3 2025
792 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q3 2025.
Moderna, Inc. - COMMON STOCK (MRNA) has 616 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 274M shares
of 385M outstanding shares and own 71.38% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (41.2M shares), BlackRock, Inc. (29.5M shares), BAILLIE GIFFORD & CO (21.8M shares), STATE STREET CORP (17.1M shares), FMR LLC (12.3M shares), MORGAN STANLEY (9.96M shares), GEODE CAPITAL MANAGEMENT, LLC (9.25M shares), Invesco Ltd. (8.22M shares), Theleme Partners LLP (8.07M shares), and TWO SIGMA INVESTMENTS, LP (7.53M shares).
This table shows the top 616 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.